microRNAs与三阴型乳腺癌研究进展
出处
《医学研究杂志》
2010年第11期8-10,共3页
Journal of Medical Research
基金
2010年上海市卫生局科研计划(2009113)
上海市重点学科建设项目(B905)
参考文献17
-
1William J,Irvin Jr,Lisa A,et al.What is triple-negative breast cancer? Eur J Cancer,2008,44(18):2799-2805.
-
2Herschkowitz JI,Simin K,Weigman VJ,et al.Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.Genome Biol,2007,8(5):R76.
-
3Nielsen TO,Hsu FD,Jensen K,et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.Clin Cancer Res,2004,10(16):5367-5374.
-
4Chuang JC,Jones PA.Epigenetics and microRNAs.Pediatric Research,2007,61(5 Pt 2):24R-29R.
-
5Colleoni M,Gelber S,Goldhirsch A,et al.Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer:International Breast Cancer Study Group Trial 13-93.J Clin Oncol,2006,24(9):1332-1341.
-
6Pritchard KI,Shepherd LE,O' Malley FP,et al.HER2 and responsiveness of breast cancer to adjuvant chemotherapy.N Engl J Med,2006,354(20):2103-2111.
-
7Piccant-Gebhart MJ,Procter M,Leyland-Jones B,et al.Trastuzumad after adjuvant chemotherapy in HER-2-positive breast cancer.N Engl J Med,2005,353(16):1659-1672.
-
8Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breast cancer:clinical features and patterns of recurrence.Clin Cancer Res,2007,13(15):4429-4434.
-
9袁中玉,王树森,高岩,苏争艳,罗文标,管忠震.305例三阴乳腺癌患者的临床特征及预后因素分析[J].癌症,2008,27(6):561-565. 被引量:161
-
10Lee Y,Kim M,Han J,et al.MicroRNA genes are transcribed by RNA polymerase Ⅱ.EMBO J,2004,23(20):4051-4060.
二级参考文献19
-
1Perou C M, Sorlie T, Eisen M-B, et al. Molecular portraits of human breast tumors [J]. Nature, 2000,406(6797) :747-752.
-
2van't Veer L J, Dai H, van de Vijver M J, et al. Gene expression profiling predicts clinical outcome of breast cancer [J ]. Nature, 2002,415(6871 ) : 530-536.
-
3Sotiriou C, Neo S Y, McShane L M, et al. Breast cancer classification and prognosis based on gene expression profiles from a population based study [J]. Proc Natl Acad Sci USA, 2003,100(18) : 10393-10398.
-
4Rakha E A, El-Sayed M E, Green A R, et al. Prognostic markers in triple-negative breast cancer [J]. Cancer, 2007, 109( 1 ) : 25-32.
-
5Jones C, Nonni A V, Fulford L, et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation [ J ]. Br J Cancer, 2001,85 ( 3 ) : 422-427.
-
6Nielsen T O, Hsu F D, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [J]. Clin Cancer Res, 2004, 10 (16) :5367-5374.
-
7Banerjee S, Reis-Filho J S, Ashley S, et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy [J]. J Clin Pathol, 2006,59(7):729-735.
-
8Carey L A, Dees E C, Sawyer L, et al. The triple negative paradox : primary tumor chemosensitivity of breast cancer subtypes [J]. Clin Cancer Res, 2007,13(8) :2329-2334.
-
9Chu K C, Lamar C A, Freeman H P. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment [J]. Cancer, 2003, 97( 11 ) : 2853-2860.
-
10Cunningham J E, Butler W M. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis [ J ]. Breast Cancer Res Treat, 2004,88 (2) : 161-176.
共引文献160
-
1范兴超,邹力君.两种新辅助化疗方案对于三阴性乳腺癌缓解率的观察及分析[J].世界最新医学信息文摘,2020(81):18-19.
-
2田富国,罗飞,赵浩亮.Aurora激酶A在三阴性乳腺癌中的表达及与临床病理特征的相关性[J].中国药物与临床,2011,11(S1):5-7. 被引量:2
-
3陈晓耕,林志武,柳燕,林镇和.三阴性乳腺癌的临床病理特点及预后因素分析[J].福建医科大学学报,2009,43(2):172-174. 被引量:4
-
4周涛,杨丽,马国明,李春晓,白杨,赵冀安,王小玲,耿翠芝.三阴性乳腺癌的临床特征及预后分析[J].中华医学杂志,2009,89(32):2261-2264. 被引量:12
-
5倪新初,孙苏平.乳腺癌的分子亚型及治疗策略研究进展[J].癌症进展,2009,7(4):422-426. 被引量:5
-
6柴文英,程若川,蒋爱梅.三阴性乳腺癌的研究进展[J].云南医药,2009,30(5):598-603.
-
7倪新初,朱玉兰,孙苏平,于静萍,王坚,李毅,孙志强,胡莉筠,关乃夫,张旭光.293例乳腺癌患者术后预后因素分析[J].临床肿瘤学杂志,2009,14(12):1113-1117. 被引量:5
-
8蔡欣,高雪,胡冬梅,屈虹,田源,刘基巍.三阴性乳腺癌的临床特点和生存分析[J].临床肿瘤学杂志,2010,15(1):52-54. 被引量:5
-
9刘桂超,邬蒙.三阴乳腺癌的研究进展[J].实用癌症杂志,2010,25(1):97-99. 被引量:12
-
10杜彩文,陈宏武,黄文河,张国君,洪超群,陈炯玉,魏晓龙,马长春.三阴性乳腺癌患者的临床特点及预后分析[J].中国现代医药杂志,2010(2):16-19. 被引量:8
-
1李万湖,陈兆秋,申洪明.乳腺癌的MRI诊断[J].肿瘤防治杂志,2003,10(11):1217-1219. 被引量:1
-
2郭变琴,吴立翔,汪先桃,涂植光.Wnt2在乳腺癌组织及患者血清中的表达及意义[J].细胞与分子免疫学杂志,2013,29(6):633-636. 被引量:6
-
3苏泼曼.EB病毒与侵袭性乳腺癌有关[J].国外医学情报,2001,22(6):42-43.
-
4袁志敏,杜静平.使用抗生素与乳腺癌危险之间关系[J].新医学,2004,35(12):770-770.
-
5靶向治疗乳腺癌[J].经济导报(医药技术),2006(1):14-15.
-
6Siegmann KC,Müller KT,Vogel U,Krauss K,Claussen CD,庞颖.乳腺癌和乳腺组织接受新辅助治疗前后的MR强化特点及T_2信号强度的分析[J].放射学实践,2011,26(2):189-189.
-
7阮伶.C-erbB-2、nm23在侵袭性乳腺癌中表达的预后意义[J].广西医科大学学报,1999,16(6):780-781.
-
8王泓(摘译).赫赛汀可根治侵袭性乳腺癌[J].中华医学信息导报,2007,22(21):19-19.
-
9范盼红,赵文月,邹佳芮,马威,张晴晴,李连宏.Genistein对乳腺癌MDA-MB-231细胞增殖、侵袭和迁移能力的影响[J].中国医科大学学报,2013,42(10):873-877. 被引量:2
-
10屈丽岩,康晓艳,宋霞.抗血管生成药物联合EGFR-TKI在晚期NSCLC治疗中的应用[J].国际肿瘤学杂志,2017,44(1):57-59. 被引量:5